8 diciembre 2014
A new analysis of an important trial of the blood pressure-lowering procedure, renal denervation, shows that the main results may have been affected by a number of confounding factors that partially explain the unexpected blood pressure responses in patients. The analysis identified factors in the SYMPLICITY HTN-3 trial, such as variations in the way the procedure was performed and changes in patients’ medications and drug adherence, which may have had a significant impact on the results.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/vPxjjwBc_xE/141208105431.htm
